Cocrystal Historical Financial Ratios
| COCP Stock | USD 1.98 0.02 1.02% |
Cocrystal Pharma is presently reporting on over 105 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 0.6 or Days Sales Outstanding of 110 will help investors to properly organize and evaluate Cocrystal Pharma financial condition quickly.
Cocrystal |
About Cocrystal Financial Ratios Analysis
Cocrystal PharmaFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Cocrystal Pharma investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Cocrystal financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Cocrystal Pharma history.
Cocrystal Pharma Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Cocrystal Pharma stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Cocrystal Pharma sales, a figure that is much harder to manipulate than other Cocrystal Pharma multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from Cocrystal Pharma's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Cocrystal Pharma current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.At this time, Cocrystal Pharma's Inventory Turnover is relatively stable compared to the past year. As of 12/11/2024, Payables Turnover is likely to grow to 13.03, while Days Sales Outstanding is likely to drop 110.09.
| 2021 | 2023 | 2024 (projected) | Payables Turnover | 0.41 | 12.41 | 13.03 | Days Of Inventory On Hand | 113.31 | 101.98 | 96.88 |
Cocrystal Pharma fundamentals Correlations
Click cells to compare fundamentals
Cocrystal Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cocrystal Pharma fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 7.44 | 17.16 | 8.89 | 0.4 | 0.63 | 0.6 | |
| Book Value Per Share | 0.81 | 0.95 | 0.88 | 4.86 | 2.73 | 2.6 | |
| Free Cash Flow Yield | (0.008935) | (0.0112) | (0.0185) | (1.35) | (0.89) | (0.85) | |
| Operating Cash Flow Per Share | (0.0491) | (0.18) | (0.14) | (2.63) | (1.52) | (1.6) | |
| Capex To Depreciation | 1.48 | 1.53 | 0.27 | 0.19 | (0.085) | (0.0808) | |
| Pb Ratio | 7.44 | 17.16 | 8.89 | 0.4 | 0.63 | 0.6 | |
| Free Cash Flow Per Share | (0.0536) | (0.18) | (0.14) | (2.64) | (1.53) | (1.61) | |
| Roic | (0.006352) | (0.73) | (1.86) | (0.18) | (0.98) | (0.7) | |
| Net Income Per Share | (1.51) | (0.17) | (0.16) | (4.77) | (1.86) | (1.96) | |
| Cash Per Share | 0.23 | 0.6 | 0.66 | 4.56 | 2.73 | 1.99 | |
| Pocfratio | (122.3) | (91.67) | (54.19) | (0.74) | (1.13) | (1.19) | |
| Capex To Operating Cash Flow | (0.0928) | (0.0244) | (0.004088) | (0.003452) | (0.008046) | (0.008448) | |
| Pfcf Ratio | (111.92) | (89.49) | (53.97) | (0.74) | (1.12) | (1.18) | |
| Days Payables Outstanding | 137.7K | 1.0K | 880.88 | 927.61 | 29.4 | 27.93 | |
| Income Quality | 0.0324 | 1.02 | 0.9 | 0.55 | 0.82 | 0.77 | |
| Ev To Operating Cash Flow | (118.08) | (88.38) | (49.62) | 0.98 | 0.54 | 0.57 | |
| Pe Ratio | (3.97) | (93.32) | (48.58) | (0.41) | (0.92) | (0.97) | |
| Return On Tangible Assets | (5.11) | (0.27) | (0.24) | (0.95) | (0.58) | (0.6) | |
| Ev To Free Cash Flow | (108.05) | (86.27) | (49.42) | 0.97 | 0.53 | 0.56 | |
| Earnings Yield | (0.25) | (0.0107) | (0.0206) | (2.45) | (1.08) | (1.03) | |
| Net Debt To E B I T D A | 0.14 | 3.48 | 4.22 | 0.96 | 1.26 | 1.33 | |
| Current Ratio | 3.62 | 25.05 | 38.4 | 33.04 | 8.92 | 5.93 | |
| Tangible Book Value Per Share | 0.21 | 0.61 | 0.66 | 4.86 | 2.73 | 2.87 | |
| Graham Number | 5.24 | 1.93 | 1.78 | 22.84 | 10.71 | 10.17 | |
| Shareholders Equity Per Share | 0.81 | 0.95 | 0.88 | 4.86 | 2.73 | 2.6 |
Pair Trading with Cocrystal Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Cocrystal Stock
Moving against Cocrystal Stock
| 0.64 | AMGN | Amgen Inc | PairCorr |
| 0.63 | ABBV | AbbVie Inc | PairCorr |
| 0.6 | TTOO | T2 Biosystms | PairCorr |
| 0.58 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.57 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.
The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.